Cited by 136Chronic Obstructive Pulmonary Disease (COPD) ResearchCystic Fibrosis Research AdvancesOral microbiology and periodontitis research

Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa

Open access
Millares, L., Ferrari, R., Gallego, M., Garcia-Nuñez, M., Pérez-Brocal, V., Espasa, M., Pomares, X., Monton, C. +2 more·2014·European Journal of Clinical Microbiology & Infectious Diseases

Abstract

The bronchial microbiome in severe COPD during stability and exacerbation in patients chronically colonised by Pseudomonas aeruginosa (PA), has not been defined. Our objective was to determine the characteristics of the bronchial microbiome of severe COPD patients colonised and not colonised by P. aeruginosa and its changes during exacerbation. COPD patients with severe disease and frequent exacerbations were categorised according to chronic colonisation by P. aeruginosa. Sputum samples were obtained in stability and exacerbation, cultured, and analysed by 16S rRNA gene amplification and pyrosequencing. Sixteen patients were included, 5 of them showing chronic colonisation by P. aeruginosa. Pseudomonas genus had significantly higher relative abundance in stable colonised patients (p = 0.019), but no significant differences in biodiversity parameters were found between the two groups (Shannon, 3 (2-4) vs 3 (2-3), p = 0.699; Chao1, 124 (77-159) vs 140 (115-163), p = 0.364). In PA-colonised patients bronchial microbiome changed to a microbiome similar to non-PA-colonised patients during exacerbations. An increase in the relative abundance over 20 % during exacerbation was found for Streptococcus, Pseudomonas, Moraxella, Haemophilus, Neisseria, Achromobacter and Corynebacterium genera, which include recognised potentially pathogenic microorganisms, in 13 patients colonised and not colonised by P. aeruginosa with paired samples. These increases were not identified by culture in 5 out of 13 participants (38.5 %). Stable COPD patients with severe disease and PA-colonised showed a similar biodiversity to non-PA-colonised patients, with a higher relative abundance of Pseudomonas genus in bronchial secretions. Exacerbation in severe COPD patients showed the same microbial pattern, independently of previous colonisation by P. aeruginosa.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10096-013-2044-0

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Culture-independent studies comparing bacterial communities at baseline and during exacerbations in the airways of patients with COPD, cystic fibrosis, or bronchiectasis consistently report no increase in bacterial burden and no decrease in community diversity during exacerbations.

    “With remarkable consistency, all studies report no increase in bacterial burden and no decrease in community diversity during exacerbations.”

    From The microbiome and critical illness (2016) · cites this paper as [133]

  • In exacerbation states, membership of the lung bacterial community shifts, often towards enrichment of the Proteobacteria phylum.

    “In exacerbation states, membership of the lung bacterial community shifts, often towards enrichment of the Proteobacteria phylum”

    From The microbiome and critical illness (2016) · cites this paper as [133]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 57 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Millares, L., Ferrari, R., Gallego, M., Garcia-Nuñez, M., Pérez-Brocal, V., Espasa, M., Pomares, X., Monton, C., Moya, A., & Monsó, E.
Affiliations
  • Universitat de València (ES)
  • Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES)
  • Corporació Sanitària Parc Taulí (ES)
  • Universitat Autònoma de Barcelona (ES)
Corresponding author
Monsó, E.
Venue
European Journal of Clinical Microbiology & Infectious Diseases
Published
2014-01-22
Volume
33
Issue
7
Pages
1101-1111
ISSN
  • 0934-9723 (ISSN-L)
  • 1435-4373
OpenAlex
W2069385595
Cited by
136
References
57
Citations by year
2026: 3 · 2025: 4 · 2024: 14 · 2023: 8 · 2022: 16 · 2021: 9 · 2020: 12 · 2019: 14 · 2018: 15 · 2017: 16 · 2016: 13 · 2015: 8 · 2014: 4
FWCI
10.94
Type
journal article
Language
en
Open access
Locations
  • European Journal of Clinical Microbiology & Infectious Diseases (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Ministerio de Economía y Competitividad (SAF2012, SAF 2012-31187)
  • Generalitat Valenciana (Prometeo/2009/092)
  • Sociedad Española de Neumología y Cirugía Torácica
  • Instituto de Salud Carlos III (Marató de TV3)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
  • Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
Keywords
chronic obstructive pulmonary disease, COPD exacerbations, sputum microbiota, bacterial diversity, potentially pathogenic microorganisms, Streptococcus, Moraxella, Haemophilus, Neisseria, Corynebacterium, Achromobacter
MeSH terms
Aged, Aged, 80 and over, Bronchi, DNA, Bacterial, DNA, Ribosomal, Female, Humans, Male, Middle Aged, Molecular Sequence Data, Phylogeny, RNA, Ribosomal, 16S, Sputum, Cohort Studies, Cluster Analysis, Sequence Analysis, DNA, Pulmonary Disease, Chronic Obstructive, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review